Concurrent Investment Advisors LLC Grows Stock Holdings in Cardinal Health, Inc. $CAH

Concurrent Investment Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 5.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,890 shares of the company’s stock after purchasing an additional 483 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Cardinal Health were worth $1,494,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CAH. Wellington Management Group LLP raised its holdings in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI raised its holdings in shares of Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after purchasing an additional 927,950 shares in the last quarter. Nuveen LLC bought a new stake in shares of Cardinal Health in the 1st quarter valued at about $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new stake in shares of Cardinal Health in the 1st quarter valued at about $104,951,000. Institutional investors own 87.17% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners boosted their price objective on shares of Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Finally, Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Trading Up 1.0%

NYSE:CAH opened at $155.72 on Thursday. The company has a market cap of $37.00 billion, a PE ratio of 24.14, a P/E/G ratio of 1.30 and a beta of 0.71. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The company’s 50 day moving average is $151.90 and its two-hundred day moving average is $151.48.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s payout ratio is currently 31.63%.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. This trade represents a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last 90 days. 0.12% of the stock is owned by insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.